Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

503 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer.
Mierzwa ML, Aryal M, Lee C, Schipper M, VanTil M, Morales K, Swiecicki PL, Casper KA, Malloy KM, Spector ME, Shuman AG, Chinn SB, Prince MEP, Stucken CL, Rosko AJ, Lawrence TS, Brenner JC, Rosen B, Schonewolf CA, Shah J, Eisbruch A, Worden FP, Cao Y. Mierzwa ML, et al. Among authors: lawrence ts. Clin Cancer Res. 2022 Dec 1;28(23):5049-5057. doi: 10.1158/1078-0432.CCR-22-1522. Clin Cancer Res. 2022. PMID: 36107219 Free PMC article. Clinical Trial.
Gemcitabine-mediated radiosensitization.
Lawrence TS, Eisbruch A, Shewach DS. Lawrence TS, et al. Semin Oncol. 1997 Apr;24(2 Suppl 7):S7-24-S7-28. Semin Oncol. 1997. PMID: 9194476 Review.
Radiosensitization by gemcitabine.
Lawrence TS, Eisbruch A, McGinn CJ, Fields MT, Shewach DS. Lawrence TS, et al. Oncology (Williston Park). 1999 Oct;13(10 Suppl 5):55-60. Oncology (Williston Park). 1999. PMID: 10550827 Free article. Review.
Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study.
Eisbruch A, Shewach DS, Bradford CR, Littles JF, Teknos TN, Chepeha DB, Marentette LJ, Terrell JE, Hogikyan ND, Dawson LA, Urba S, Wolf GT, Lawrence TS. Eisbruch A, et al. Among authors: lawrence ts. J Clin Oncol. 2001 Feb 1;19(3):792-9. doi: 10.1200/JCO.2001.19.3.792. J Clin Oncol. 2001. PMID: 11157033 Clinical Trial.
Radiosensitization by pan ErbB inhibitor CI-1033 in vitro and in vivo.
Nyati MK, Maheshwari D, Hanasoge S, Sreekumar A, Rynkiewicz SD, Chinnaiyan AM, Leopold WR, Ethier SP, Lawrence TS. Nyati MK, et al. Among authors: lawrence ts. Clin Cancer Res. 2004 Jan 15;10(2):691-700. doi: 10.1158/1078-0432.ccr-1041-03. Clin Cancer Res. 2004. PMID: 14760092
503 results